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Abstract 
 
Bone grafts comprise a multibillion dollar industry, with over a million grafts occurring each 
year around the world. These grafts are commonly autologous or allogenic. Autologous grafts 
are taken from the patient, and are sourced from a donor site from the patient’s body. Allogenic 
grafts are derived from a cadaver donor. Each of these graft types are associated with issues such 
as donor site morbidity in autologous grafts and immunological response in allogenic grafts. 
Bone tissue engineered constructs are a logical approach to combat the issues 
commonly encountered with current autologous and allogenic bone grafting techniques. While it 
is possible to grow bone tissue engineered constructs in vitro, it is necessary to destroy the 
construct to determine the number and type of cells present. Recent work has led to the 
development of models that have the potential to predict the number and types of cells within the 
construct through metabolite monitoring. The metabolites, such as glucose and oxygen, are used 
to monitor cell growth while the construct remains in the bioreactor, eliminating the need to lyse 
cells and destroy the scaffold. This allows for the development of quality assurance 
methodologies that are explicitly utilized on the specific graft to be used on a patient. These 
models, however, neglect to account for factors affecting the construct, such as flow rate and 
scaffold geometry. This study aimed to determine the flow characteristics present within the 
bioreactor system, and hoped to quantify the effects of these characteristics on oxygen uptake 
rates of mesenchymal stem cells. The work done utilized a residence time distribution analysis 
using an easily monitored dye to develop residence time distribution functions, and associated 
these functions with literature values to characterize the flow patterns and residence times of 
media moving through the construct. Findings indicate that flow within the bioreactor system is 
well approximated by linear tubular flow reactors, associated with gradients in the radial 
	 xi	
direction at low flow rates. Additionally, oxygen uptake rates of stem cells in these conditions 
have a strong linear correlation with residence times of media in the cassette, providing the data 
needed to develop a predictive model for oxygen uptake rates. These models also show promise 
for providing corrective functions for on-line oxygen monitoring systems in current bioreactor 
designs. 
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1. Introduction 
1.1 Relevance and Current Market 
Bone damage due to trauma or disease is prevalent worldwide. In many instances, a bone 
graft is required to treat such damage. A bone graft is the term referring to an intricate matrix of 
transplanted bone, or bone substitute that aids in the repair or replacement of a damaged bone. 
Over 500,000 patients receive bone grafts annually in the United States and Europe, and 430,000 
incidents worldwide involve autologous bone [1, 2]. The total cost of bone grafts in the United 
States and Europe was estimated to be $3 billion in 2012, and is only expected to increase in the 
coming years [1]. This rising demand for bone grafts provides a prime market for a viable 
alternative to current standards in orthopedics and dentistry. 
 
1.2 Bone Graft Characterization  
Current solutions for bone defects typically center on the use of various graft types 
including autologous grafts, allogenic grafts, and xenografts [3-6]. These bone grafts differ in 
where they are sourced. Autologous bone grafts are taken from a separate location on the 
patient’s body, oftentimes the iliac crest [2, 7]. Allogenic grafts are sourced from a cadaver [4, 5, 
8]. Xenografts are bone grafts taken from another species, and prepared to serve as a calcified 
matrix [4]. Each of these grafts has benefits and downsides. Autologous grafts rarely suffer from 
immunological response, as they are sourced from the patient’s own body, and maintain good 
osteogenic, osteoconductive, and osteoinductive properties [5, 7, 9]. However, donor site 
morbidity, pain, and infection have high incidence rates, even with current surgical techniques 
[2, 7, 9, 10]. Additionally, autologous grafts have limited availability, and can lead to additional 
complications such as fat embolisms and deep vein thrombosis [11, 12]. Allogenic grafts have 
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higher availability, in addition to maintaining osteoconductive and some osteoinductive 
characteristics [4]. These grafts also show comparable results to autografts when treated with 
osteogenic factors, such as bone morphogenetic proteins [8]. Furthermore, allografts are the main 
source of grafts for large bone defects [13]. Still, these grafts suffer from issues revolving around 
immunological response, mechanical properties from sterilization techniques, and high 
variability due to source [4, 9]. Lastly, xenografts have been shown to give promising results in 
dentistry, but have been shown to result in foreign body reactions and infection in orthopaedic 
applications, even though they are biocompatible [4, 14]. With each of these graft types, defect 
size plays a large role in determining the success of the graft [15]. Union rates are high for 
autologous grafts when compared to allogenic, especially when utilizing vascularized autologous 
grafts [6, 16]. Allogenic also have poor long-term outcomes, and often result in fracture and bone 
density loss [13]. However, allogenic grafts are often required for many arthroplasty revisions, as 
autogenic sources have been depleted [12, 13]. These revisions have good short-term outcomes, 
but long-term outcomes are highly variable [13]. 
Tissue engineered grafts aim to serve as an alternative to previous graft types mentioned, 
as they have the potential to maintain good osteogenic, osteoconductive, and osteoinductive 
characteristics. Furthermore, the size and morphology of the tissue engineered graft has the 
ability to be modified for a particular patient. Synthetic bone grafts have been used more 
recently. Early trials involving hydroxyapatite ceramics as alternatives for autologous grafts 
yielded promising results [17]. From there, work has been completed on the use of various 
osteoconductive polymeric or ceramic scaffolds infused with osteoinductive growth factors and 
pre-osteoblastic cells [3, 6]. These tissue-engineered grafts, though they show initial results 
consistent with autologous grafts, are not currently the go-to option for bone grafts [18, 19]. 
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However, these recent results do show that they could potentially reach a point where they 
outperform autologous grafts [18]. 
 
1.3 Tissue Engineering Approach 
Tissue engineering was originally described over 30 years ago as a combination of 
engineering and life sciences [20]. This approach has developed dramatically since then, and is 
now the basis for over 100 companies generating over $3.5 billion in sales each year [21]. The 
overarching goal of tissue engineering is to provide an alternative means of tissue replacement 
throughout the human body. It centers on three main criteria: biodegradable scaffolds, patient 
derived cells grown on these scaffolds, and chemical signals provided to cells to allow for 
differentiation into necessary cell types [20].  
 
1.4 Challenges Facing Tissue Engineered Bone Grafts 
Current challenges in tissue engineering focus on finding reproducible means to create 
tissue engineered constructs that are viable for transplants into humans. Existing methodologies 
require the destruction of constructs to determine their characteristics such as cellularity, 
development of extracellular matrices, and cell type. Due to this, FDA approval is hindered by 
the absence of appropriate predictive models that need to be developed. While many solutions 
exist to determine similar characteristics in 2D systems, 3D systems lack predictive models to 
accurately and consistently describe the important factors that will ultimately allow us to bring 
tissue engineered bone constructs to a large-scale production. This is especially true when 3D 
cell/scaffold constructs are cultured in flow perfusion bioreactors. 
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Furthermore, nutrient transfer to interiors of bone constructs is a hurdle that has yet to be 
completely addressed [22, 23]. Vascularization of bone grafts is a barrier due to the fact that 
scaffold design is insufficient to promote architecture that mimics native tissue in its entirety [23, 
24]. Even more, complete control of nutrients to cells, specifically oxygen, is vital to ensure that 
cells behave in a manner that is consistent with native tissue [23]. However, current bioreactor 
designs neglect to take this into consideration. Static cultures of 3D cell/scaffold constructs 
remain heavily utilized although they generate often the most severe nutrient limitations to cells 
residing deep inside these scaffolds. 
 
1.5 Characterization of Natural Bone Tissue 
3D tissue engineered bone constructs need to maintain certain physiological aspects to be 
consistent with natural bone present in body. As such, it is important to have a thorough 
knowledgebase of what constitutes bone. Bone is a living tissue, containing an organic structure 
of approximately 95% Type I collagen strengthened with calcium salts [25]. Within this structure 
live four types of bone cells: osteoblasts, osteoclasts, osteocytes, and bone lining cells [25, 26]. 
Each of these cells completes a different task within the bone, allowing for continued upkeep and 
remodeling of bones within the body [26]. Two types of bone are present in the body: cortical 
and cancellous [25, 27]. The physiological differences between these two types allows for 
heightened function of skeletal bone throughout the body, where cortical is compact and 
provides mechanical and protective roles while cancellous bone is the primary site for metabolic 
functions [25].  
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1.6 Cell Types and Functions  
The variety of cells present in bones have progenitor cells such as mesenchymal stem 
cells and hematopoietic cells residing in the bone marrow. Mature and differentiated cells inhabit 
the bone, itself, or leave the bone entirely through the blood stream [28]. Bone modeling and 
remodeling are completed primarily through two cell types: osteoblasts and osteoclasts; however, 
bone lining cells and osteocytes also play large roles in the development and maintenance of 
bone structure [29, 30]. Each of these cell types interact with each other through the secretion of 
factors including, but not limited to, proteins, cytokines, hormones, and extracellular matrices 
[31-34]. It is with these factors that cells are recruited to particular locations within the bone, and 
bone remodeling takes place in basic multicellular units on the surface of the bone [31, 33]. 
These factors also induce differentiation in progenitor cells, as bone remodeling relies on a 
specific balance of each cell type in the basic multicellular unit [30, 33]. Mesenchymal stem cells 
are the progenitor cells for the osteoblastic lineage, whereas hematopoietic stem cells are the 
progenitor cells for osteoclasts [29]. Osteoclasts’ primary function is to reabsorb the bone matrix 
in response to local defects [26]. The osteoblastic lineage is composed of osteoblasts, and the 
two terminally differentiated cell lines osteocytes and bone lining cells [30]. The primary 
purpose of osteoblasts is to secrete extracellular matrix to build up the bone, while osteocytes 
and bone lining cells help control the level of remodeling occurring in a particular area of bone 
[29, 30]. Osteocytes are cells buried within the bone matrix, and provide signaling to the other 
cell types depending on a variety of factors including mechanical loading [35]. Bone lining cells 
are found on the surface of bone, and aid in cell recruitment in response to mechanical stress, and 
have been found to return to an osteoblastic state in response to mechanical stimuli [30, 36]. 
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Furthermore, bone lining cells serve a vital role in controlling osteoclast activity and the 
formation of the basic multicellular unit [26]. 
Mesenchymal stem cells clearly play a large role in the development and maintenance of 
bone in the body, as they are the progenitor cells for osteoblasts, osteocytes, and bone lining cells 
[29]. These cells were originally identified in the mid-20th century, but were not recognized as 
playing a role in regeneration of tissue until more recently. Early research on mesenchymal stem 
cells revealed their highly proliferative properties, and showed they could be properly controlled 
to differentiate into different lineages in vitro [37]. Other research identified their potential to be 
used in regenerative medicine, as they were able to be extracted, differentiated, and re-implanted 
into the body and perform the activities of that cell in vivo [38]. Since then, work has been 
completed, and mesenchymal stem cells are much more well-characterized. To be considered a 
mesenchymal stem cell, certain criteria must be met. Originally outlined by The International 
Society for Cellular Therapy, these cells must be adherent to plastic, differentiate in to 
chondrocytes, osteoblasts, and adipocytes, and express certain surface markers to be considered 
mesenchymal stem cells [39, 40]. The large diversity in functions of mesenchymal stem cells has 
been increasingly researched, and now it is seen that these cells even play roles in immunological 
responses speed of healing [41, 42].  
 
1.7 Physical Characterization of Bone Matrix 
 Two types of bone are found in the body, cortical and cancellous, and each of these types 
maintains different physical characteristics. Cortical bone is highly organized and contains 
packed collagen fibrils in the form of lamellae [25]. These lamellae run perpendicular to each 
other, and help form much of the structural support [25]. Cancellous bone is much more porous, 
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with no regular matrix [25]. Each of these bone types maintain comparable mineralization. Bone 
in the body is composed of approximately 50 to 70% mineral, 20 to 40% organic matrix, and 5 to 
10% water [27]. Of the minerals present, the major one is calcium and phosphate in the form of 
hydroxyapatite [25, 27]. Other minerals include carbonate, magnesium, and acid phosphate [27]. 
The organic portion of the bone is a majority collagen, and helps give the bone elasticity and 
flexibility [27, 43]. In understanding the native bone morphology, proper scaffolds, cell types, 
and chemical cues can be selected to ensure a final tissue engineered bone construct will reflect 
the natural tissue it aims to replace. 
 
1.8 3D Bioreactor Systems 
Many different types of 3D bioreactor systems exist, such as spinner flask, rotating flask, 
and flow perfusion systems [44]. Each of these systems provides particular properties relating to 
shear stresses experienced by constructs and mass transfer of nutrients to cells. Flow perfusion 
bioreactors function by flowing nutrient and oxygen rich media through the construct, promoting 
cell migration to the center of constructs and providing controlled mechanical stimulation [44, 
45]. The system is arranged by placing a scaffold seeded with cells within a cassette. This 
cassette serves as a means of holding the tissue engineered construct in place as media perfuses 
through it. Media is circulated through the system, with most contained in a reservoir outside the 
bioreactor setup [46]. A media inlet and outlet are positioned on the top and bottom of the 
scaffold, and media is perfused through the mesh scaffold seeded with cells [46]. Flow perfusion 
systems correct for common issues encountered in both spinner flask and rotating flask 
bioreactors, like the development of a fibrous layer surrounding the construct or absence of cell 
proliferation [46, 47]. Flow perfusion systems manage to mitigate these negative attributes while 
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also providing increased control over physical characteristics like shear stresses and mass 
transfer of nutrients to the cells, and function best for bone differentiation experiments [45, 48]. 
 
1.9 Factors in 3D Bioreactor Systems 
 A variety of considerations must be made when designing flow perfusion systems. In 
these system types, flow characteristics, scaffold architecture, and presence of cells and 
extracellular matrices can have large effects on the local mass transfer properties and mechanical 
stimulation experienced by the cells in the reactor. 
 
1.9.1 Effects of Flow in Perfusion Bioreactors 
 Flow perfusion bioreactors have been selected for bone tissue engineering applications 
for two primary reasons centering on mass transfer and mechanical stimulation. In early 
bioreactor designs, mass transfer to the center of 3D scaffolds was completed primarily through 
diffusion; however, flow perfusion flows media directly through the interconnected pores of a 
scaffold, mitigating most mass transport limitations [49-51]. Furthermore, the direct control of 
this mass transport phenomena alone was found to have a direct effect on cell behavior in larger 
tissue engineered constructs [52, 53]. Flow perfusion also provides mechanical stimulation in the 
form of shear stress. Shear stress has been shown to have a positive effect on the differentiation 
of mesenchymal stem cells into osteoblasts [49, 52, 54, 55]. Even more, increased shear stress is 
directly proportional to the deposition of mineralized matrices [51, 56]. However, while the mass 
transport and shear stress environments produced by fluid flow showed direct effects on the 
cells’ behavior, these two aspects have been shown to be highly dependent on the scaffold 
geometries used in each application [57]. 
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1.9.2 Effects of Scaffold Architecture 
 As flow characteristics vary greatly with scaffold geometry, it is important to have 
knowledge of how each scaffold will behave in a given tissue engineering application [57]. 
Scaffolds also play a large role in cell behavior and construct success due to their surface 
characterization, overall geometry, and material characteristics [58-60]. In an overarching sense, 
material choice will be one of the primary indicators of how well a scaffold will perform. 
Materials will change based on the specific application, and these materials need to have clearly 
described mechanical properties, degradation rates, and biological activity [61]. Material choice 
is especially important when considering the necessity of having a modifiable scaffold that is 
tailored to a particular patient [60]. Scaffold architecture has a significant effect on construct 
success, as porosity, pore size, and overall geometry will strongly dictate the flow characteristics 
and microenvironments experienced by cells in a flow perfusion system [61]. Rapid prototyping 
is a potential solution to these issues, but the current state of manufacturing technologies is 
unable to consistently produce scaffolds with these porosity and pore size requirements in 
materials that are biologically relevant [60].  
 
1.9.3 Summary of Effects 
Both of these bioreactor characteristics, flow rate and scaffold type, are greatly related as 
they each have drastic effects on determining cell fate and the development of an extracellular 
matrix. Flow is a contributing factor to shear stress and mass transfer properties experienced by 
cells in a tissue engineered construct. Scaffold characteristics such as pore size and porosity also 
have an effect on both shear stress and mass transfer, in addition to dictating the 
microenvironments experienced by cells. Additionally, scaffold choice will involve aspects such 
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as material and geometry, both of which are highly associated with manufacturing technique. In 
all, it is important to have extremely characterized systems to maintain consistent predictive 
measures for a tissue engineered construct. 
 
1.10 Monitoring Techniques for Tissue Engineering Bioreactors 
Recently, monitoring techniques for these constructs have been developed allowing for 
continuous data to be collected. As such, on-line measurements hope to bypass the destructive 
means by which constructs are currently evaluated. 
 
1.10.1 Oxygen Sensing 
 Oxygen has long been seen as a potential indicator for metabolic activity, cell 
proliferation, and cell culture success. Various designs for measured oxygen uptake rate have 
been developed for both 2D and 3D systems, with implications ranging from cellular biomass 
monitoring to 3D tissue engineered constructs [62-68]. 2D culture systems quantify diffusion of 
oxygen into media and compare these values to oxygen readings at or below the cells present in 
the culture [69, 70]. These monitoring techniques utilize a fluorescent dye in a material that is 
read with a fiber optic probe or fluorescent microscope, with the latter system using oxygen 
beads to map local oxygen gradients across a plate [69, 70]. Most 3D perfusion systems use a 
similar fluorescent dye material to monitor oxygen entering and exiting the construct, but 
alternative systems where electrodes are used have proven successful at high cell densities [64-
68, 71]. Flow perfusion systems that measure oxygen uptake have been shown to give linear 
relationships with metabolic activity and cell proliferation in a 3D construct, allowing for a non-
destructive means to monitor cells in vitro [63, 64, 68]. Differentiating cells have been shown to 
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change metabolic pathways, thereby changing oxygen uptake rates, but oxygen monitoring in 
conjunction with other on-line monitoring systems has been shown to account for these changes 
and predict the time-point where differentiation takes place [65]. 
  
1.10.2 Glucose Sensing 
 A variety of methods for measuring glucose concentrations in solutions have been 
developed. Each of these systems provides a potential option to monitor tissue engineered 
constructs continuously on-line. Amperometric sensors that are rhodinized carbon based have 
been developed to determine the concentration of glucose in a continuous manner [72, 73]. These 
sensors utilize an enzymatic reaction between glucose and glucose oxidase, and show high 
selectivity for glucose in medium solutions [72]. Other sensors used also center on the 
exploitation of glucose oxidase, however these are in direct contact with an oxygen sensitive 
material and a fiber-optic probe [74]. This design provides continuous measurements for at least 
24 hours, in addition to maintaining high selectivity even in the presence of oxygen and other 
metabolites in the system [74]. Generally speaking, glucose oxidase is a vital component when 
determining glucose concentration in bioreactor systems. 
 Work completed by Simmons et al. and Meuwly et al. showed promising results for 
glucose to serve as an indicator of cellularity and differentiation [65, 75]. Glucose has been 
shown to reliably monitor proliferation in cell dense systems, in addition to serving as a 
dependable control for controlling cell behavior like productivity [75]. Furthermore, glucose can 
be used in conjunction with other monitoring systems, such as oxygen, to aid in determining both 
cellularity and progress of differentiation [65]. 
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1.10.3 Resazurin Based Assays (AlamarBlueTM and Presto BlueTM) 
 Resazurin has long time been a common indicator of cytotoxicity and cell viability [76-
78]. Originally used in static 2D systems, high linearity and sensitivity have been seen, but 
recently work has been done to determine the potential of resazurin based assays to function in 
3D bioreactor systems [76, 77, 79-81]. These assays are correlated with metabolic activity of the 
cells, and mainly focused on determining relationships with metabolic activity and cellularity 
readings in 3D perfusion systems. Initial research showed resazurin has a strong indicator of 
cytotoxicity and metabolic activity, even in 3D systems, as was evident by linear correlations of 
resazurin reduction with increasing time [78, 79]. However, the use of either AlamarBlueTM or 
Presto BlueTM to determine cellularity in 3D perfusion systems has been debated. 
 Research by Sonnaert showed that consistent results were seen when using resazurin 
reduction to determine cellularity in 2D, static 3D, and perfusion 3D systems [76]. This 
investigation used corrective factors to adjust for flow and diffusion. Other studies have found 
that resazurin assays in perfusion systems did correlate to cellularity, but only under certain 
conditions. Zhou saw that greater linearity was seen for proliferating cells as opposed to cells 
that had reached maximal cell density [80]. However, in a study completed Uzarski, the 
proliferation phase of cells had a large effect on the assay due to the available concentration of 
reagent in the system, leading to skewed cellularity results at higher cell densities [81]. Lastly, it 
has been seen that, when compared to DNA assays, resazurin based assays show inconsistent 
results for cellularity for multiple cell types [82]. 
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1.10.4 Complex Permittivity 
Complex permittivity is a methodology comparable to dielectric spectroscopy, 
specifically oriented towards tissue engineered constructs. Initial studies showed that complex 
permittivity measurements are able to determine the porosity of scaffolds, scaffold defects, and 
the presence of cells within a 3D scaffold [83]. Even more, morphological differences in cells 
can be evaluated, thereby indicating the extent of differentiation of stem cells [84]. However, this 
approach has encountered issues with defining the effects of extracellular matrices on the 
permittivity readings [84]. 
 
1.10.5 Monitoring Techniques Summary 
Many of these techniques neglect to account for system dependent characteristics such as 
flow rate of media through the tissue engineered construct and the type of scaffold used. As such, 
these monitors are very system specific, and have little control in alternative systems. This 
highlights the importance of developing widely applicable correctional factors for cell specific 
characteristics such as oxygen uptake rate and glucose uptake rate, as these traits are central to 
determining tissue engineered construct characteristics in a non-destructive manner.    
 
1.11 Effects of Oxygen on Cell Behavior 
 Oxygen tension has been shown to have a significant effect on cell behavior, especially in 
differentiating cells [85-87]. In the broadest sense, oxygen uptake rates by cells varies greatly 
depending on oxygen availability. In static systems, oxygen delivery is completed through 
diffusion alone, causing significant gradients for any system seeded with cells in a manner 
comparable to 3D constructs [85, 88]. For 2D systems, where diffusion though a scaffold is not a 
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factor, stem cells were shown to model Michaelis-Menten kinetics in oxygen uptake rates with 
varying oxygen concentrations [89]. Studies determining the effects of hypoxic and normoxic 
conditions on mesenchymal stem cell behavior show that hypoxia causes a decrease in the cells 
ability to differentiate [86, 87]. Even more, extended culturing of stem cells in hypoxic 
conditions has been shown to maintain undifferentiated state of these cells [87]. The reasoning 
for this likely centers on oxidative phosphorylation, as stem cells experiencing differentiation 
have a marked shift to oxidative phosphorylation for production of ATP from other metabolic 
pathways [86, 90]. This shift to oxidative phosphorylation is associated with mitochondrial 
biogenesis and reliance on glutamine availability [90, 91]. Oxygen uptake rate is also correlated 
with oxygen availability in perfusion systems, where increased superficial flow velocity 
correlated with increased oxygen uptake rates [92]. Furthermore, perfusion systems where 
oxygen gradients were below 5% were shown to still produce viable cells after two weeks in 
culture [93]. 
 
1.12 Summary of Goals 
By monitoring the relationship present between oxygen uptake rate and oxygen 
availability, predictive models can be developed to determine the optimal flow rates for specific 
cell types, the potential effects of scaffold geometries, and the final construct characteristics 
through traditional oxygen and glucose monitoring techniques for a flow perfusion system. 
These models will take into account residence time of media in the construct, as this quality can 
more easily be applied to other 3D bioreactor systems. This will ultimately allow for cellularity 
and differentiation models to be expanded further, as different tissue engineering goals will 
require different bioreactor and scaffold types. 
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1.13 Objectives and Scope of Project 
The primary objective of this investigation is to determine the effects of flow rate on 
oxygen uptake rate in non-differentiating mesenchymal stem cells. This objective involves 
characterizing the flow present within the flow perfusion system, and developing predictive 
models for cellularity and oxygen uptake rates based on flow. 
Furthermore, oxygen uptake rate in mesenchymal stem cells in 2D systems has been 
shown to follow Michaelis-Menten kinetics, but current studies show that the behavior of cells 
and their uptake rates differ drastically in a 3D flow perfusion environment. It is a goal of this 
investigation to understand these differences in cell behavior as an aid designs for future 
bioreactors and monitoring systems in tissue engineering applications. 
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2. Methods 
2.1 Cell Culture 
Rat mesenchymal stem cells (rMSC) were used for all experiments conducted. Cells were 
extracted from the bone marrow of rat femurs and tibias using methods approved by the 
University of Oklahoma Institutional Animal Care and Use Committee (IACUC). Rats used were 
6 week old male Winstar rats weighing approximately 175-199 grams (Envigo; Hsd:Wi). To 
isolate rMSCs, bone marrow from femur and tibia of rear legs was first extracted and suspended 
in a-Minimum Essential Media (aMEM; Sigma Aldrich) that was supplemented with 10% Fetal 
Bovine Serum (FBS; Atlanta Biologicals), and then distributed evenly into T75 cell culture 
flasks and allowed to incubate (37°C, 95% humidity, 5% CO2) for 4 days. Cultures were then 
gently rinsed with phosphate buffered saline (PBS; Sigma-Aldrich) to remove non-adherent 
cells. Remaining cells were considered passage zero rMSCs, and were either passaged for 
immediate use or placed into cryogenic storage. 
All cell cultures and bioreactors used aMEM supplemented with 10% FBS and 1% 
antibiotic/antimycotic (Life Technologies). Prior to seeding in the bioreactor, cells were 
incubated at 37°C, 95% humidity, and 5% CO2 until they reached 80% confluency, at which 
time they were lifted using trypsin (Sigma-Aldrich), centrifuged at 1100 RCF for 5 minutes to 
create a cell pellet, suspended in aMEM, and distributed into T75 cell culture flasks at a 
concentration of 375,000-500,000 cells per flask. During expansion of cells, media was changed 
every other day. All studies were completed with cells at passage two.  
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2.2 Scaffold Production and Preparation 
Spunbonded fiber scaffolds were utilized due to their high seeding efficiencies and 
reproducibility, and were made in accordance with previously published procedures [94]. These 
fibers were composed of randomly arranged poly(l-lactic acid) (PLLA) fiber layers that were 
stacked and compressed to form a sheet of 20 µm diameter fibers with approximately 85% 
porosity. PLLA (NatureWorks LLC; grade 6251D; 1.4% D enantiomer; MW=108,500 kDa) 
pellets were used to produce the fibers. Scaffold disks approximately 1.25 mm in height and 8 
mm in diameter were cut from sheets of spunbonded fibers for use in bioreactor systems. 4 
individual scaffold disks were used per cassette, creating a single scaffold approximately 5 mm 
in height and 8 mm in diameter. 
Following ethylene oxide sterilization (AnPro 74iTM), scaffold disks were placed into 
95% ethanol and a vacuum was pulled on the container to purge air from the interior of the 
scaffolds. Once all air had been removed from the scaffold disks, they were submerged in sterile 
PBS to leach out remaining ethanol. Scaffold disks were then placed in aMEM supplemented 
with 50% FBS, and placed into the incubator for two hours prior to seeding to facilitate cell 
attachment. 
 
2.3 Bioreactor Setup and Seeding 
Bioreactor bodies were assembled prior to cell seeding. Assembly involved placing the 
cassette into the bioreactor body and connecting tubing to the reservoir system. Cassettes used 
are cylindrical containers that hold scaffolds in the bioreactor body. Furthermore, they have 
rubber seals at the top and bottom to ensure flow passes through the scaffolds, and not around the 
periphery of the cassette. Figure 1 shows a diagram of the bioreactor body, cassette, and scaffold 
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setup. The system was purged of air in the biological hood by flowing media through the system. 
It was then allowed 4 hours to reach an equilibrium temperature of 37°C in the incubator. To 
prepare cells for seeding, they were first lifted and centrifuged to create a cell pellet, and then 
suspended in aMEM at a concentration of 2 million cells per 150 µL.  
 
Figure 1: Cross-sectional View of Bioreactor 
Cassette fits into bioreactor body, and contains a tapered bottom to ensure consistent positioning 
of scaffolds. Four scaffold disks were used for each construct. Media was perfused from the top 
of the bioreactor body, through the scaffolds, and out the exit at the bottom. 
 
To complete the seeding, two individual scaffold disks were placed into the cassette, 75 
µL of the cell suspension was pipetted onto the scaffolds, another single scaffold disk was placed 
into the cassette, 75 µL of the cell suspension was pipetted onto the scaffold disk, and finally the 
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last scaffold disk was placed into the cassette. Immediately following seeding of each construct, 
the bioreactors were placed into the incubator where a modified version of oscillatory seeding 
was completed. The flow of media through the construct was first allowed to flow in the forward 
direction at 150 µL/min for 1 minute, and was then reversed and allowed to flow in the backward 
direction at 150 µL/min for 1 minute. This was completed for 30 minutes, ending in the reverse 
direction. Following the oscillatory seeding procedure, the cells were allotted 2 hours to adhere 
to the scaffolds, wherein no flow was present in the system. The entire volume of media in the 
bioreactor and reservoir systems was then replaced to remove un-adhered cells from the system. 
 
2.4 Oxygen Data Collection 
The method by which oxygen concentrations were collected revolved around the use of 
RedEyeTM oxygen sensing patches (Ocean Optics). These patches were contained within an 
oxygen sensing module (OxyMod), originally developed by Simmons et al. [65]. Media was 
found to be saturated at the entrance to each cassette, so oxygen concentrations were measured at 
the exit of the bioreactor body to determine total oxygen consumed by the cells. Each of the 
OxyMod sensors was calibrated to 0.173 mmol O2/L and 0 mmol O2/L concentrations in 
deionized water prior to each setup. The sensors contained a material integrated into the sensor 
matrix. This material contained two fluorescent molecules, ruthenium and Pt-porphyrin 
complexes [95]. The fluorescence of this material is correlated to the oxygen concentrations in 
the media [95]. A fiber optic probe emitting blue light at 450 nm excited the material, and the 
resulting fluorescence was captured using the same probe. This data was then transferred to the 
NeoFox Viewing SystemTM, and fluorescence data was related to the oxygen concentration in 
media using the Stern-Volmer equation [95].  
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Oxygen data was collected once, 2 days after initial seeding. Prior to data collection, all 
bioreactors were run at 150 µL/min. To complete data collection, the desired flowrate was 
adjusted and allowed to reach equilibrium for 45 minutes. Immediately following the 45-minute 
time period, oxygen data was collected for the exiting stream of each construct. The flow was 
then changed to the next flow rate, and another 45 minutes was allotted to reach equilibrium. The 
flow rates tested were 150 µL/min to 750 µL/min, increasing by 150 µL/min for each trial. All 
testing was completed within 3 hours, so the effects of cell proliferation were assumed to be 
zero. As non-differentiating media was used, it was assumed that flow rate, and the resulting 
shear stress changes, would have no effect on the oxygen uptake rate change as seen in 
differentiating cells. As a precaution, samples were collected both for flow rates incrementally 
increasing from 150 µL/min to 750 µL/min and for flow rates incrementally decreasing from 750 
µL/min to 150 µL/min.  
Readings taken from the NeoFox Viewing SystemTM were oxygen saturation values 
ranging from 0% to 100%, where 100% was the maximum oxygen saturation for media 
calculated using Henry’s Law. The percent saturation values for the exiting stream were used to 
find the concentration of oxygen in the exiting stream, and this value with the flowrate was used 
to determine the oxygen uptake rate (OUR) for the construct (Equation 2.1). 𝑂𝑈𝑅$%&'()*+( = 𝐶./,1& − 𝐶./,%*( ∗ 𝑄															𝑬𝒒𝒖𝒂𝒕𝒊𝒐𝒏	𝟐. 𝟏 
Where: 
𝐶./,1& = Entering	oxygen	concentration	 µmolL  
𝐶./,%*( = Exiting	oxygen	concentration	 µmolL  𝑄 = Volumetric	Flow	Rate	 Lhr  
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The OUR of the construct was then used to find the OUR on a per cell basis. Zero order kinetics 
were assumed to find an average OUR value per cell, in accordance with Equation 2.2. 
𝑂𝑈𝑅+WXX = 𝑂𝑈𝑅+%&'()*+(𝑁+WXX 															𝑬𝒒𝒖𝒂𝒕𝒊𝒐𝒏	𝟐. 𝟐 
Where: 𝑁+WXX = Number	of	cells 
 
2.5 Cellularity Quantification 
Immediately following all oxygen data collection scaffolds were removed from each 
cassette, gently rinsed with sterile PBS, and placed into individual microcentrifuge tubes 
containing 1 mL nanopure water. Each scaffold was subjected to 3 freeze/thaw cycles utilizing a 
freezer at -20 °C. Freeze thaw cycles were completed over two days, where samples were frozen 
for 12 hours, thawed, and refrozen. The resulting mixture constituted the cell lysate for each 
sample taken. The cell lysate was used to determine the total number of cells adhered to the 
scaffold of each cassette. A double stranded (ds) DNA assay with standards (Quant-iT PicoGreen 
dsDNA Assay; Life Technologies) was completed to determine the total amount of DNA within 
each scaffold. 43 µL of the sample or standard was first pipetted into a 96 well plate. Standard 
solutions were made at concentrations ranging from 0.1 to 3 µg DNA per mL. Then 257 µL of a 
buffer and PicoGreen solution (10 mM Tris-HCl, 1 mM EDTA, pH 7.5, 0.75 µL PicoGreen Dye) 
was pipetted into each well, and the plate was incubated at room temperature in the dark for 5 
minutes. The fluorescence was then read at an excitation wavelength of 495 nm and an emission 
wavelength of 520 nm. The standards were used to determine the amount of DNA in each 
sample. This amount of DNA was then associated with a particular cellularity, on the basis of 
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knowing the DNA content of each individual cell. For undifferentiated rMSCs, it was assumed 
that 4.5 picograms of DNA were contained in a single cell [96].  
 
2.6 Residence Time Analysis 
A residence time distribution function was derived from experimental data and 
subsequently integrated to determine the residence time for each flow rate tested in the bioreactor 
setup. Experimental design was adapted from work completed by Simmons [96]. A step input 
system was utilized for all tests completed, whereby DI water initially filled the system. A dye 
solution containing Trypan Blue (0.4% in Solution; Sigma) was then pumped through the 
scaffold and cassette combination, and the exiting stream was analyzed for dye composition 
(c(t)). To do this, absorbance measurements at 590 nm were taken of the elute, and compared to 
an absorbance measurement of 100% dye solution prior to passing through the system (c0). 
Breakthrough time (tbt), the time at which dye was first detected in the elute, was recorded. 
Samples were then collected every 30 seconds, and data collection stopped after the elute 
reached 99% of the initial concentration of dye, with the final reading constituting the final time 
point (tf). This data was then fit to Equation 2.3 [96]. Equation 2.3 has previously been shown 
to fit closely the concentration profiles produced by the residence time distribution analysis. 
𝑐 𝑡 = 𝑐` − 𝑐`1 + 𝑡 − 𝑡c(𝐶d $/ ∗ 1 −𝑊 + 𝑐` ∗ 𝑊															𝑬𝒒𝒖𝒂𝒕𝒊𝒐𝒏	𝟐. 𝟑 
Where: 
𝑊 = 𝑡 − 𝑡c(𝑡g − 𝑡c( 𝐶d	𝑎𝑛𝑑	𝐶k = Curve	fitting	parameters 
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A least squares regression was conducted to fit experimental data to Equation 2.3. The resulting 
formula was then utilized to determine the cumulative distribution function, F(t), and the 
residence time distribution function, E(t), shown by Equations 2.4 and 2.5.  
𝐹 𝑡 = 𝑐(𝑡)𝑐` 															𝑬𝒒𝒖𝒂𝒕𝒊𝒐𝒏	𝟐. 𝟒 
𝐸 𝑡 = 𝜕𝜕𝑡 𝐹 𝑡 = 𝜕𝜕𝑡 𝑐 𝑡𝑐` 															𝑬𝒒𝒖𝒂𝒕𝒊𝒐𝒏	𝟐. 𝟓 
The residence time could be calculated by taking the following integral: 
𝐴𝑣𝑒𝑟𝑎𝑔𝑒	𝑅𝑒𝑠𝑖𝑑𝑒𝑛𝑐𝑒	𝑇𝑖𝑚𝑒 = 	𝜏 = 𝑡𝐸 𝑡 𝑑𝑡															𝑬𝒒𝒖𝒂𝒕𝒊𝒐𝒏	𝟐. 𝟔(`  
A numerical integration was completed to determine the average residence time, and the 
resulting values for each flow rate were used for oxygen uptake rate analysis. Analysis was run 3 
times per flow rate. 
 Experimental data was also used to determine the theoretical residence time for different 
reactor types that could potentially serve as a model for our bioreactor setup. For plug flow 
reactors, the residence time was determined using Equation 2.7. 
𝑀𝑒𝑎𝑛	𝑅𝑒𝑠𝑖𝑑𝑒𝑛𝑐𝑒	𝑇𝑖𝑚𝑒 = 𝜏X* = 𝑆𝑐𝑎𝑓𝑓𝑜𝑙𝑑	𝑉𝑜𝑖𝑑	𝑉𝑜𝑙𝑢𝑚𝑒𝑉𝑜𝑙𝑢𝑚𝑒𝑡𝑟𝑖𝑐	𝐹𝑙𝑜𝑤	𝑅𝑎𝑡𝑒 = 𝜋 ∗ 𝑟k ∗ ℎ ∗ 𝜖𝜈 					𝑬𝒒𝒖𝒂𝒕𝒊𝒐𝒏	𝟐. 𝟕 
Where: 
𝜈 = Volumetric	Flow	Rate	 mLsec  𝑟 = Scaffold	Radius	(cm) ℎ = Scaffold	Height	(cm) 𝜖 = 𝑃𝑜𝑟𝑜𝑠𝑖𝑡𝑦 
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 The residence time for a tubular laminar flow reactor was also calculated after 
determining if the flow in the bioreactor system was laminar using the Reynolds number. The 
Reynolds number was found using Equation 2.8. 
𝑅𝑒𝑦𝑛𝑜𝑙𝑑𝑠	𝑁𝑢𝑚𝑏𝑒𝑟 = 𝑅𝑒 = 𝜌𝑉𝑑𝜇 															𝑬𝒒𝒖𝒂𝒕𝒊𝒐𝒏	𝟐. 𝟖 
Where: 
𝜌 = 𝐹𝑙𝑢𝑖𝑑	𝐷𝑒𝑛𝑠𝑖𝑡𝑦	 𝑘𝑔𝑚  𝑉 = 𝐹𝑙𝑢𝑖𝑑	𝑆𝑢𝑝𝑒𝑟𝑓𝑖𝑐𝑖𝑎𝑙	𝑉𝑒𝑙𝑜𝑐𝑖𝑡𝑦	 𝑚𝑠𝑒𝑐  𝑑 = 𝑆𝑐𝑎𝑓𝑓𝑜𝑙𝑑	𝐷𝑖𝑎𝑚𝑒𝑡𝑒𝑟	 𝑚  
𝜇 = 𝐷𝑦𝑛𝑎𝑚𝑖𝑐	𝑉𝑖𝑠𝑐𝑜𝑠𝑖𝑡𝑦	 𝑘𝑔𝑚 ∗ 𝑠𝑒𝑐  
Once the Reynolds number was determined, any value less than 2300 was considered laminar 
flow [97]. 
 To determine the theoretical residence time for the laminar tubular reactor, the residence 
time distribution function was approximated using Equation 2.9 [97]. 
𝐸 𝑡 = 𝜏k2 ∗ 𝑡 															𝑬𝒒𝒖𝒂𝒕𝒊𝒐𝒏	𝟐. 𝟗 
Where: 𝜏 = 2 ∗ 𝐵𝑟𝑒𝑎𝑘𝑡ℎ𝑟𝑜𝑢𝑔ℎ	𝑇𝑖𝑚𝑒	(𝑡c() 𝑡 = 𝑇𝑖𝑚𝑒	(𝑠𝑒𝑐𝑜𝑛𝑑𝑠) 
The average residence time was then calculated using a numerical integration as shown in 
Equation 2.6. 
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 Following residence time analysis, a visual study was completed to determine the flow 
patterns within the construct. The Trypan Blue (MW=872.88 g/mol) dye solution was pumped 
through the scaffold until dye was initially seen in the effluent. Once dye was detected in the 
effluent, flow was stopped, and scaffold disk layers were removed from the cassette. As 4 
stacked scaffold disks were used for all bioreactors and analysis run, these 4 scaffold disks were 
taken out and each layer was analyzed for dye present. This was completed to visually confirm 
flow geometries within the scaffold. 
2.7 Statistical Analysis 
Following data collection and analysis, a one-way ANOVA was conducted to determine 
if there was a significant effect (p-value < 0.05). If significance was incurred, a post hoc Tukey’s 
test was run to find which individual groups were statistically significant.  
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3. Results and Discussion 
 Results are discussed in a stepwise manner, where analysis proceeds in the order which 
data was obtained. This aids in providing a comprehensive understanding of why the primary 
objectives of this project were completed and how they were analyzed.   
3.1 Oxygen Concentration Drop 
The concentration of oxygen entering and exiting the construct was used to determine the 
uptake rate by the constructs, and ultimately on a per cell basis. Prior to determining these 
values, the drop in media oxygen concentration having moved through the construct was 
measured.  
 
Figure 2: Oxygen Drop Across Construct 
The total concentration drop in oxygen across the construct is shown in comparison to the flow 
rate. As flow rate was increased, a linear decrease in oxygen concentration drop across the 
construct can be seen. A linear regression was performed and a slope of -2.6x10-5 was found 
with an R2 value of 0.98. Dashed lines show the 95% confidence interval for the linear 
regression analysis. Error bars represent mean ± SEM. A sample size of n=8 was used for 
analysis. 
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As flow rate of media through the construct increased, a linear decrease in oxygen drop 
was observed. Figure 2 shows this decreasing trend. As flow rate increases, larger amounts of 
oxygen are delivered to the cells within the construct. It is expected that the concentration of 
oxygen in media leaving the construct would increase, thereby yielding a lower net change in 
oxygen concentration. These values of oxygen concentration were then used to determine the 
rate of oxygen consumed by the entire construct. 
 
3.2 Oxygen Uptake Rate Per Construct 
 
Figure 3: Oxygen Uptake Rate per Construct 
Oxygen uptake rate on a per construct basis is shown as flow rate is changed. As flow rate 
increased, a linear increase in oxygen uptake rate for the construct was initially observed. After 
a flow rate of 450 µL/minute was reached, the uptake rate plateaued at approximately 0.65 
µmol/hr/construct. Error bars represent mean ± SEM. A sample size of n=8 was used for 
analysis. ANOVA with Post-hoc Tukey’s test completed to calculate significance “*” (p < 0.05). 
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 To determine the total amount of oxygen consumed by the construct, the oxygen drop 
across the construct was multiplied by the flowrate, giving a time dependent value of oxygen 
consumption by the construct, as a whole. Figure 3 shows an initial linear trend for the uptake 
rate, which proceeded to plateau at approximately 0.65 µmol/hr/construct. While these values of 
oxygen uptake rate are indicative of the general trends expected for oxygen uptake rate, they are 
unable to form a predictive model for cellularity. As it is unknown what effects flow may have, it 
was important to determine the oxygen uptake rate on a per cell basis for each flow tested. These 
values of oxygen uptake rate were divided by the respective cellularity of that construct to 
determine the oxygen uptake rate per cell.  
 
3.3 Cellularity Quantification 
Construct analysis yielded cellularity values for use in oxygen uptake rate analysis. A 
single bioreactor setup was used for all ensuing experiments. All constructs were analyzed for 
DNA quantity, and this DNA concentration was used to determine the cellularity of the construct 
by dividing the total DNA by 4.5 picograms DNA per cell for non-differentiating MSCs. An 
average cellularity of 224,069 ± 18,410 cells was used for analysis. Figure 4 presents a box and 
whisker graph that shows the average readings for cellularity with interquartile ranges indicated 
by upper and lower boundaries of box, media cellularity value indicated by the center line, and 
maximum and minimum values indicated by error bars. The upper and lower edges of the shaded 
box indicate the first and third quartile ranges, respectively. 
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Figure 4: Construct Cellularity 
Eight constructs were analyzed for DNA quantity, and that DNA quantity was associated with a 
cellularity. The box and whisker plot shows the 1st and 3rd quartile ranges, the median 
cellularity (indicated by line in the center of the plot), and the maximum and minimum values 
(indicated by the error bars). 
 
3.2 Oxygen Uptake Rate Per Cell 
 Oxygen uptake rates on a per cell basis show comparable trends to overall construct 
uptake rates. These rates initially see a linear increase, followed by a plateau at approximately 3 
picomoles O2/hr/cell. These values for oxygen uptake rate are consistent with values obtained by 
Simmons et al. in 3D perfusion bioreactor systems, but still an order of magnitude greater than 
other literature values [65]. In 3D systems, oxygen uptake rates for undifferentiated cells were 
approximately 1.5 picomoles O2 /hr/cell at flow rates of 150 µL/min [96]. However, in 2D 
systems, the maximum oxygen uptake rate was approximately 0.1 picomoles O2/hr/cell [89]. The 
plateau reached at 450 µL/min indicates that non-differentiating mesenchymal stem cells will 
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ultimately reach a maximum value of oxygen consumption, reaching a value that is on-par with 
differentiating stem cells in other perfusion systems. Figure 5 potentially indicates this 
relationship is solely flow based, but it is important to characterize the flow within the scaffold to 
determine the root cause of these trends. 
 
Figure 5: Oxygen Uptake Rate per Cell 
The oxygen uptake rate on a per cell basis is shown in comparison to the flow rates tested. As 
flow rate increased, a linear increase in oxygen uptake rate on a per cell basis was observed. 
After a flow rate of 450 µL/minute was reached, the uptake rate plateaued at about 3.0 picomol 
O2/hr/cell. Error bars represent mean ± SEM. A sample size of n=8 was used for analysis. 
ANOVA with Post-hoc Tukey’s test completed to calculate significance “*” (p < 0.05). 
 
 
 
	 31	
3.5 Residence Time Distribution Analysis 
 The residence time was analyzed by evaluating effluent leaving the bioreactor system. In 
Table 1 the values and constants required for Equation 2.3 are outlined. Using these values, the 
experimentally derived values for mean residence time are listed in Table 2. These residence 
times decrease with increasing flow rate. To aid in characterizing the flow in these systems, the 
normalized residence time distribution function was compared to literature graphs for plug flow 
and laminar tubular flow reactors in Appendix A.2. Additional analysis was done, whereby 
experimentally obtained values for breakthrough time and time at which effluent concentration 
reached 99% of original concentration were used to determine the theoretical mean residence 
time for laminar tubular flow reactors with fully developed flow. Experimentally obtained values 
were also compared to theoretical values of residence time for plug flow reactors. These 
comparisons are seen in Figure 6. Studies were completed in the absence of cells. 
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Table 1: Fitted Equation for Experimentally Obtained Data 
Experimentally obtained values and constants for fitted equation are shown. These values were 
collected for each flow rate tested. tbt is the breakthrough time of dye leaving the cassette; tf is 
the time at which experimentally obtained concentrations of dye leaving the cassette reach 99% 
of co; C1 and C2 are fitted constants for each flow rate, determined by a least squares regression. 
Fitted constants are shown for each run completed: 3 for each flow rate. 
Flow Rate (µL/min) tbt (seconds) tf (seconds) C1 C2 
150 – 1  103 1350 117.041 1.112 
150 – 2 180 1290 8.898 0.379 
150 – 3  167 1170 15.253 0.310 
300 – 1  63 810 10.618 0.588 
300 – 2  71 990 42.416 0.703 
300 – 3 93 870 28.218 0.703 
450 – 1  71 825 2.706 0.544 
450 – 2 39 795 1.438 0.303 
450 – 3  59 465 40.001 1.125 
600 – 1  47 795 28.468 1.249 
600 – 2  46 795 10.365 0.786 
600 – 3  47 495 28.209 1.237 
750 – 1  29 585 4.043 0.462 
750 – 2  47 585 23.718 1.326 
750 – 3 40 495 14.715 0.890 
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Table 2: Mean Residence Time Values 
Residence time for each flow was calculated 3 times using the aforementioned equation and the 
trapezoid numerical integration technique. Averages of these values are shown ± SEM. A sample 
size of n=3 was used for analysis.	
Flow Rate (µL/min) Ave. Residence Time 
(seconds) 
150 247 ± 17.6 
300 149 ± 20.8 
450 91 ± 14.2 
600 89 ± 6.3 
750 72 ± 5.3 
 
 
Prior to calculating the theoretical time for laminar tubular flow reactors, it was important 
to verify that flow within the bioreactor system for all flow rates was laminar. Reynolds numbers 
were calculated for each flow rate, under the assumption the media solution maintained similar 
viscosity and density values as water. The cutoff for laminar and turbulent flow can be 
approximated in packed bed reactors. Laminar flow is considered any value less than 1, the 
transition phase is from 1 to 100, and a Reynolds number greater than 100 is considered 
turbulent [98]. Table 3 shows that all calculated Reynolds numbers are at the cutoff for laminar 
flow, thereby showing that flow in the reactors is likely laminar. Furthermore, due to the high 
porosity of the scaffold, the cutoffs are likely lower than that for a typical packed bed reactor. 
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Table 3: Reynolds Number Values 
Reynolds Number for each flow was calculated using Equation 2.8. All calculated values are at 
or below 1, but well below 100, indicating laminar flow through construct. 
 
Flow Rate (µL/min) Reynolds Number 
150 0.6 
300 1.2 
450 1.8 
600 2.4 
750 3.0 
 
 The residence times values for laminar flow, plug flow, and experimentally obtained 
values is shown in Figure 6, where experimental values can be compared directly to what would 
be expected for each of these reactor types operating under the designated flow conditions. 
Experimental values are nearly identical to those found for laminar tubular flow reactors, and 
nearly 4 to 8 times the values obtained for plug flow reactors with no dispersion. Previous 
experiments showed that this bioreactor system was comparable to plug flow with significant 
dispersion effects, however, comparisons to theoretical values indicate that it is much closer to 
residence times seen in fully developed laminar flow with little to no dispersion [96]. It is 
important to note that these theoretical values are calculated for reactors with no porous medium, 
which differs slightly from the current setup that contains an 85% porous scaffold. 
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Figure 6: Theoretical Residence Time Comparison 
Theoretical values for residence time were computed for laminar tubular reactors and plug flow 
reactors, and then compared to experimental values. Plug flow values are significantly lower 
than experimental values, and laminar tubular reactors are very similar to experimentally 
obtained values. Error bars represent mean ± SEM. A sample size of n=3 was used for analysis. 
 
 These claims are further supported by the normalized residence time distribution function 
graphs in Appendix A.2. These graphs show the characteristic spike, followed immediately by a 
gradual decrease in the function. The presence of a scaffold, and the resulting porosity, were 
thought to have an effect on these trends. However, it may be safe to assume that since the 
scaffold porosity is so large (𝜖 =	0.85) it has negligible effects on the flow characteristics. 
Furthermore, the assumption of fully developed flow could be indicative of significant gradients 
in the radial direction, something not taken into account in previous models. 
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Figure 7: Theoretical Flow Velocity Profile 
Scaffold disk layers are shown, where top is where flow enters cassette. Theoretical flow velocity 
profile associated with fully developed flow, showing how fluid would move through scaffold. 
 
Figure 8: Anticipated Cross-sectional Dye Profile 
Assuming flow follows fully developed laminar flow through scaffolds, initial dye should be 
distributed through scaffold in the manner described above. The scaffold disks at the entrance 
are well saturated by dye, and dye continues to move in higher rates through the center of the 
scaffold. 
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Figure 9: Dye Composition per Scaffold Disk Layer 
Moving from left to right, scaffold disks are placed from the top of the cassette near the entrance 
towards the exit of the cassette. The saturation of dye in the scaffold is indicative of a fully 
developed profile, seeing as the top scaffold disk is fully saturated in dye, and moving towards 
the bottom the dye is more concentrated in the center of the scaffold disk. Tested at 750 µL/min.	
	
 Fully developed flow in pipes is characterized by a signature parabolic velocity profile 
(See Figure 7), where high flow rates are present in the center of the tube and decrease towards 
the sides. In the event this profile was present in the construct, it would be indicative of 
significant gradients in the radial direction. Figure 8 shows what initial dye saturation in the 
scaffold disk layers might look like if this type of flow was present in the bioreactor system, 
where scaffold disks near the top are nearly saturated with dye, and saturation becomes 
increasingly concentrated in the center of the construct moving downward. 
 Figure 9 shows the dye initial concentration of dye each layer of the scaffold 
immediately following the flow of dye into the system up until the breakthrough time. Scaffold 
disks were stacked in bioreactor, consistent with Figure 1, and subsequently removed from 
cassette and laid side by side, where the leftmost scaffold constitutes the top scaffold in the 
cassette. These results are consistent with the expected dye profile in Figure 8, further 
supporting the claim that fully developed laminar flow is present in the bioreactor system. 
Additionally, these results show the presence of gradients in the radial direction.  
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3.6 Oxygen Uptake Rate Relative to Residence Time 
 
Figure 10: Oxygen Uptake Rate per Cell vs. Residence Time 
Oxygen uptake rate on a per cell basis is shown in comparison to the residence time experienced 
at the associated flow rate. The relationship between residence time through the reactor at a 
particular flow rate and the OUR per cell at that flow rate indicates a linear relationship. A 
linear regression was performed. A slope of -0.0109 and a y-intercept of 3.899 were found with 
an R2 value of 0.96. Dashed lines show the 95% confidence interval for the linear regression 
analysis. Error bars represent mean ± SEM. A sample size of n=8 was used for analysis for OUR 
Cell. A sample size of n=3 was used for analysis for Residence Time. 
 
 In place of flow rate, residence time was graphed against the oxygen uptake rate on a per 
cell basis in Figure 10. The graph shows a linear relationship between the two variables, 
demonstrating  a direct relationship between residence time of media in the bioreactor system and 
the uptake rate of oxygen by cells. A linear regression was performed, and a R2 value of 0.96 
was found. A 95% confidence interval for the linear regression was graphed, and shows a high 
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level of accuracy for the predictive model. The slope and y-intercept were used to create a model 
(Equation 3.1) that relates the residence time to the cellular oxygen uptake rate in Figure 11. 
𝑂𝑈𝑅	𝐶𝑒𝑙𝑙	 𝑝𝑖𝑐𝑜𝑚𝑜𝑙𝑒	𝑂kℎ𝑟 ∗ 𝑐𝑒𝑙𝑙 = −0.0109 ∗ 𝜏 + 3.899															𝑬𝒒𝒖𝒂𝒕𝒊𝒐𝒏	𝟑. 𝟏 
Where: 𝜏 = Mean	Residence	Time 
Figure 10 also shows the potential for a maximum oxygen uptake rate for mesenchymal stem 
cells in a reactor as the residence time approaches zero, given as the y-intercept of the model. As 
stated previously, fully developed laminar flow accurately models the flow patterns within the 
bioreactor system, indicating standard parabolic velocity profiles. Due to lower velocities at the 
edges of the scaffold and higher velocities at the center of the scaffold, low flow rates would 
result in low oxygen delivery to the edges of the scaffold. Since flow would pass primarily 
through the center of the construct, diffusion of oxygen would be the primary means of oxygen 
deliver to cells located at the periphery of the tissue engineered construct. As local concentration 
of oxygen is central to cellular oxygen uptake rates, it is safe to assume that cells at the periphery 
of the construct would consume lower amounts of oxygen than those at the center, resulting in a 
lower average oxygen uptake rate on a cellular basis. As flow rate increases, it is predicted 
convective mass transfer would slowly overtake diffusive mass transfer, resulting in greater 
deliver of oxygen to the cells. The greater availability of oxygen on a local level throughout the 
construct would result in higher overall levels of oxygen uptake, until cells reached their true 
maximum uptake rate. However, efforts to approach this limit cannot be accomplished, as cell 
detachment would likely occur prior to that point due to high shear at the surface of the cells with 
high flow rates. 
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3.7 Predicted Oxygen Uptake Rate Model 
 The predictive model for oxygen uptake on a cellular basis, given residence time for the 
construct, was graphed in Figure 11 versus the experimentally obtained values for cellular 
oxygen uptake rate. 
 
Figure 11: Oxygen Uptake Rate Prediction vs. Experimental 
The predictive equation showing the relationship between residence time and OUR Cell was 
plotted against experimentally obtained values of OUR Cell for each flow rate tested. A linear 
regression was performed and a slope of 0.958 was found with an R2 value of 0.96. Dashed lines 
show the 95% confidence interval for the linear regression analysis. Error bars represent mean 
± SEM. A sample size of n=8 was used for analysis for experimental values. A sample size of 
n=3 was used for analysis for predicted values. 
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 Equation 3.1 was used to predict oxygen uptake rates, and shows a strong relationship 
between residence time and oxygen uptake rates on a per cell basis. A linear regression for the 
model was completed, and a slope of 0.958 and R2 value of 0.96 indicate a high potential for 
residence time, alone, to be an indicator oxygen uptake rate and hypothetically cellularity in the 
construct. The dashed lines in Figure 11 represent the 95% confidence interval derived from the 
linear regression, and further show the fit of the predictive model. This behavior is likely driven 
by the mitigation of gradients to extending from the center to the periphery of the scaffold. As 
such, scaffold architecture would likely have a significant effect on these predictive models. 
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4. Conclusions 
 Analysis of flow effects within the 3D flow perfusion bioreactor system used for 
production of bone tissue engineered constructs yielded results that show the importance of flow 
characterization within bioreactor systems, in addition to displaying the effects of these flow 
characteristics on the behavior of mesenchymal stem cells. Previous work completed by 
Simmons predicted the flow within the bioreactor system to be well approximated by plug flow 
with dispersion effects [96]. This work championed these findings. It highlighted the importance 
of plug flow in mitigating radial effects of flow within the reactor system, stating that shear 
stress could evenly approximated across the cross-section of the construct [96]. However, new 
results show that the flow within the reactor could better be described as fully developed laminar 
flow, causing significant radial effects in terms of shear stresses experienced by cells and 
delivery of nutrients to these cells. The standard parabolic shape of laminar flow models in tubes 
show sharp declines in fluid velocity moving from the center of the construct to the periphery, 
producing these effects. Potential side effects of these large gradients could appear in the 
upregulation of certain genes in mesenchymal stem cells, such as Hypoxia Inducible Factor 1-a 
(HIF1a), which has been shown to be a key regulation in cell activity [99]. HIF1a has been 
shown to be a key player in proliferation, indicating that gradients could have drastic effects on 
construct viability [99]. It is important to note that these results were found for spunbonded 
PLLA fibers at high porosities, allowing for the possibility of flow characteristics to change in 
other bioreactor system and other scaffold types. 
 The cell specific oxygen uptake rates found in this experiment are an order of magnitude 
larger than those found in literature. This could potentially be caused by a multitude of factors. 
First, nearly all literature values obtained are found in 2D systems, finding maximum uptake 
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rates of approximately 0.1 picomoles oxygen/cell/hour, compared to our findings of 3.02 ± 0.07 
picomoles oxygen/cell/hour [86, 89]. However, the effects of dynamic versus static culturing 
systems has been shown to have a significant effect on metabolic properties of mesenchymal 
stem cells in terms of glucose consumption [100]. These findings could be extrapolated to 
oxygen consumption, as well, since glucose and oxygen are the two primary indicators of 
metabolic rate. Additionally, cells could potentially vary metabolic rates in high confluency 
environments in 2D systems, where many of these oxygen uptake rate values were observed. Our 
system had comparatively low confluency, potentially yielding higher net oxygen uptake rates. 
 The overarching objective of this investigation was to determine a relationship between 
flow characteristics and oxygen uptake rate of cells. Our results found that a linear relationship 
existed between residence time and cell specific oxygen uptake rate. These results were also 
consistent with findings of laminar flow characteristics in our system, where higher convective 
mass transfer of oxygen, associated with lower residence time, caused higher oxygen uptake 
rates. These findings could be extrapolated using our model to determine a maximum oxygen 
uptake rate in conditions where there are no mass transport limitations, giving an absolute 
maximum cell specific oxygen uptake rate of approximately 4 picomoles/cell/hour. While these 
results would be impossible to reach, due to both limitations with flow effects on cells and mass 
transport limitations in nearly all systems, it could potentially provide insight to success of new 
bioreactor designs in terms of nutrient delivery to cells within a tissue engineered construct. The 
predictive model could also serve as a corrective factor for other systems relying on on-line 
oxygen measurements to determine cellularity.  
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5. Future Directions 
 
 This study has provided preliminary data highlighting the effects of flow characteristics 
in a bioreactor system on cell behavior. Furthermore, it has exposed weaknesses in current 
models used for nutrient delivery and shear stress analysis. In order to completely reap the 
benefits of flow analysis, it is necessary to account for other variables in tissue engineering 
bioreactor systems. 
 Initially, the flow rates tested were completed towards the lower end of flow rates 
previously used in this system. The current bioreactor design is capable of reaching 3 mL per 
minute. It would be important to observe oxygen uptake rates at these flow rates to determine if a 
maximum oxygen uptake rate of 3.02 ± 0.07 picomoles oxygen/cell/hour was truly reached. 
Furthermore, it could yield additional residence time analysis to conclude if flow characteristics 
within the bioreactor system change at maximum flow rates. 
The effects of these oxygen concentrations on cell behavior needs to be studied. It would 
be important to determine if extended exposure to high oxygen availability will have any effects 
on regulation of processes within the cell. Additionally, it would be of interest to determine if the 
excess of oxygen could have an effect on the rate of differentiation of mesenchymal stem cells 
into osteoblasts. 
 These experiments for oxygen consumption would also need to be completed at varying 
cellularity and confluency within the construct. These models were reached using only one cell 
density, and cell density could potentially have a large effect on the metabolism of the cells and 
therefore the cell specific uptake rate. Since this would ultimately serve as a predictive measure 
for bone tissue engineered constructs, experiments would need to be completed for 
differentiating cells as they are known to increase oxygen consumption as they proceed through 
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osteoblastic differentiation. Scaffold geometries could also play a large role in flow 
characteristics throughout the constructs, so repeating residence time distribution analysis with 
varying scaffold geometries would further allow these results to be extrapolated to other 
bioreactor designs. Scaffold geometry could also play a large role in radial gradients, and give 
insight on how to mitigate them. 
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Appendix 
A1. Supplemental Methodologies 
A1.1 Extraction of Rat Mesenchymal Stem Cells 
Rat mesenchymal stem cells (rMSC) were used for all experiments conducted. Cells were 
extracted from the bone marrow of rat femurs and tibias using methods approved by the 
University of Oklahoma Institutional Animal Care and Use Committee (IACUC). Rats used were 
6 week old male Winstar rats weighing approximately 175-199 grams (Envigo; Hsd:Wi). 
Following order and delivery, rats were placed in the animal housing facility (Laboratory 
Animal Resources) for 3 to 4 days to allow for rats to acclimate to new environment. Once the 
acclimation period was complete, rats were collected and brought back to the lab for cell 
extraction. Rats were asphyxiated one by one in a CO2 chamber using approved methods 
(American Association for Laboratory Animal Science) whereby CO2 was added to the chamber 
at 10% the total chamber volume per minute. Following asphyxiation, all CO2 was expelled from 
the chamber before the next rat was introduced to the asphyxiation chamber. Immediately 
following the death of the rat, the lower half of the rat (hips down to rear feet) was shaved, and 
then the rat was submerged in 95% ethanol for 5 minutes. The rat was then removed from the 
ethanol and placed onto the surgical area. A surgical pad was utilized to isolate the desired leg, 
by forming a small hole in the center of the pad and placing the leg through it. TriodineTM was 
rubbed on entirety of leg to further sterilize the incision site. 
A long incision was first made on the lateral side of the leg from hip to the ankle. First, 
muscle and connective tissues were cut away from the femur, and the ligament at the hip was cut 
to allow the femur head to be removed. Muscle and connective tissues were then cut away from 
tibia, and the ankle joint was severed to allow full removal of the femur and tibia. The knee was 
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severed at the distal end of the femur and the proximal end of the tibia. The two bones were then 
placed in bone media. Bone media is comprised of normal aMEM without any FBS 
supplementation. The same process was completed for the other leg.  
The bones, bone media, sterile bone cutters, and sterile forceps were placed in the 
biological hood. Additionally, aMEM supplemented with 10% FBS was warmed to 37 °C and 
placed under the hood. 3 mL syringes (BD 3mL Syringe; 309657) and 20 gauge filter needles 
(Braun; FN-5120) were filled with media, and set to the side until bones were prepared. Two 
syringes were prepared for each bone. One by one, bones were removed from the bone media. 
Femurs were cut at the proximal end with bone cutters, and needles were inserted approximately 
1 cm into the distal end, and media was flushed through the bone, carrying the bone marrow into 
a sterile 15 mL falcon tube (Corning; 352196). Tibias were cut at the distal end, and needles 
were inserted approximately 1 cm into the proximal end of the bone. Again, bone marrow was 
flushed from the bone using media. The bones from each leg were kept separate from other legs, 
as was the bone marrow. The bone marrow was then broken up and suspended in same media 
used to flush bones, and split evenly between 5 cell culture flasks (Corning; 430641U). Each 
flask was supplemented with aMEM to a final volume of 10 mL. Flasks were then placed into 
the incubator set to 37°C, approximately 95% humidity, and 5% CO2 for 4 days. Flasks were 
then gently rinsed with PBS, and 10 mL of aMEM was added to each flask. Mesenchymal stem 
cells at this step were considered Passage Zero. Cells were fed every other day from that point 
on, and ultimately passaged or stored cryogenically once reaching 80% confluency. 
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A1.2 Cryogenic Storage of Cells 
Mesenchymal stem cells used in the experiments were occasionally frozen cryogenically 
for storage. Cryogenic media was first prepared. Cryogenic media is composed of 90% FBS 
(Atlanta Biologicals; S11150; Lot K13149) and 10% dimethyl sulfoxide (DMSO) (Sigma-
Aldrich; 472301-2.5L). Cells growing in culture flask (Corning; 430641U) were rinsed with 5 
mL PBS. Once rinsed, 1 mL trypsin (Sigma-Aldrich; T4049-100ML) was added to the flask, and 
incubated for 6 minutes (37 °C, 5% CO2, 95% humidity) to lift the cells. Cells were then rinsed 
from the flask using 9 mL aMEM and placed in a 15 mL falcon tube (Corning; 362196). The 
cells were well mixed, and a small sample of approximately 0.2 mL was taken to count cells 
using a hemocytometer (Bright-Line; 1492). The remaining cells were centrifuged at 1100 rpm 
for 5 minutes, creating a cell pellet. Media was carefully removed using a vacuum line, and the 
cell pellet was redistributed in cryogenic media at a concentration of approximately 1 million 
cells per mL. The cell/cryogenic media solution was pipetted into cryogenic vials (1 mL each), 
and the vials were placed in Mr. Freeze (Nalgene; 5100-0001) and placed in a -80 °C freezer for 
12-24 hours. The vials were then transferred to liquid nitrogen cryogenic storage. 
Cells were plated from cryogenic storage by first removing the cells from liquid nitrogen 
and thawing. The cells and cryogenic media was then pipetted into a cell culture flask, and 
supplemented with 10 mL aMEM. The following day, all media was pulled off and 10 mL fresh 
media was added to each cell culture flask. From that point on, media was changed every other 
day and normal cell passaging occurred. 
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A1.3 Oxygen Sensor Production 
Oxygen sensing modules located at the exit of each bioreactor cassette were designed to 
allow for accurate measurement of oxygen concentration in the media leaving the bioreactor 
body. To do so, they were comprised of tubing impermeable to oxygen, a glass housing for the 
RedEyeTM oxygen sensing patch, and an outer cover to mitigate signal loss due to ambient light. 
The design of the current sensors used were based on OxyMods originally produced by Simmons 
[96]. Design modifications were completed to correct for issues encountered with first generation 
model. 
 
Figure 12: Oxygen Sensing Module Cover 
The oxygen sensing module cover has three main features that aid in oxygen concentration 
measurements: (A) the white plastic used aids in reducing background noise, (B) viewing 
window to check for air in reactor line, and (C) a cylindrical guide for the probe used in oxygen 
measurments. 
 
The outer cover seen in Figure 12 was designed in SolidWorks, and provides 3 main 
benefits. First, the cover itself is 3D printed from white material. Original OxyMods used white 
tape around the perimeter of the sensor to aid in sensor readings, so the cover helps level out 
oxygen readings by providing a solid white background while also blocking ambient light in 
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room. Second, the cover has a small opening at the top which provides a viewing window to 
check for air in the sensor. As air will affect the readings, checking for air in the sensor is an 
important step before measuring oxygen levels in media. Last, the cover has a cylinder that 
serves as a guide for the probe connected to the NeoFox Viewing SystemTM. The location a 
reading is taken on the oxygen sensing patches greatly affects the measurement output, so a 
guide ensures consistent readings are taken. 
The inner portion of the sensor was comprised of square tubing (FD #175494) cut into 
lengths of approximately 1 inch. The oxygen sensing material (Ocean Optics; RE-FOS-4-KIT) 
was placed in the center of a single side, and the outer cover was slid over the glass tubing, 
ensuring the probe guide was lined up with the RedEyeTM patch. Water proof epoxy was then 
used to glue two 1/8 inch barbed fittings to the entrance and exit of the sensor, while also gluing 
the cover over the glass tubing. Figure 12 shows what the assembly looks like without the cover 
or the oxygen sensing patch. 
 
Figure 13: Inner Oxygen Sensing Module Chamber 
The entrance and exit of the glass tubing have barbed tubing connectors to allow for easy 
attachment to the exit of the bioreactor system. 
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A1.4 Oxygen Sensor Calibration 
Prior to running the bioreactor systems, all oxygen sensors were calibrated to 0% 
saturated and 100% saturated oxygen conditions within the bioreactor system. 100% saturation 
calibrations were completed by constructing the bioreactor system, filling it with DI water in 
place of media, and placing it in the incubator to reach equilibrium temperature and dissolved 
oxygen. After media circulated through the reactor system for 12 hours, the sensors were read 
using the NeoFox Viewing SystemTM probe, where values for Tau were collected as a reading 
outputted by the program. Each of these values were recorded as 100% oxygen values. To read 
0% oxygen values, a comparable system was setup. A single reservoir was utilized, where a 
diffusing stone was placed in the DI water to disperse nitrogen gas. Once the water was saturated 
with nitrogen, it was pumped through the oxygen sensor through oxygen impermeable tubing. 
This tubing was adjusted to be as short as possible. After allowing 4 hours to reach equilibrium 
at room temperature, a reading for Tau was taken. Since it was difficult to set up the 0% oxygen 
system in the incubator, it was found that room temperature produced comparable results. These 
two values of Tau were used in the two-point calibration on the NeoFox Viewing SystemTM for 
oxygen measurements during the bioreactor run. 
 
A1.5 Oxygen Data Collection 
The entire bioreactor system shown in Figure 13 shows the typical organization of the 
bioreactor system used for flow perfusion tissue engineering. Each of these individual 
components is connected by oxygen permeable tubing. This allows for complete restoration of 
oxygenation of media prior to media reentering the bioreactor body. The peristaltic pump 
provides control over flow rate of media to tissue engineered constructs located in the bioreactor 
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body, and the reservoir ensures sufficient media is present for supplementation of oxygen, 
glucose, and other necessary nutrients. 
 
Figure 14: Bioreactor System 
The bioreactor system shown consists of (A) peristaltic pump, (B) reservoir system, and (C) the 
bioreactor body. 
 
 
Figure 15: Bioreactor Body 
The bioreactor body is the central component to the bioreactor system, where the tissue 
engineered construct is stored and monitoring components are attached. 
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The bioreactor body is comprised of multiple parts. The inlet to the tissue engineered 
construct is located at the top of the body. Media then flows down into the cassette where the 
construct is housed. Media perfuses through the construct, where oxygen is used by the cells. At 
the exit of the body is the oxygen sensor. This sensor relies on a patch containing ruthenium and 
Pt-porphyrin, florescent molecules that have altered properties in the presence of oxygen.  
 
Figure 16: Oxygen Sensing Module 
Oxygen sensing modules are located at the immediate exit of the reactor system, providing 
accurate measurement of oxygen levels in media leaving construct. 
 
After exiting the bioreactor, the media flows through a small section of yellow tubing that 
has low gas permeability (See Figure 15). This tubing ensures that the oxygen concentration at 
the exit of the construct is the same as what is read by the oxygen sensor. The media then flows 
into the body of oxygen sensor, a housing that contains an internal glass tube surrounded by a 3D 
printed holder. This 3D printed object provides a solid white background (something that 
increases precision of oxygen measurements) and also gives a guide for the probe used to 
measure oxygen. The circle seen in the center of the housing is the guide, with the center open to 
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allow access to the oxygen patch. This oxygen sensing patch is located inside the glass tubing, 
where it can come in direct contact with the media exiting the bioreactor body. The small 
opening above the probe guide is used as an indicator for air that has leaked into the system. In 
the presence of air, the sensor no longer functions for media oxygen concentration 
measurements. 
 
Figure 17: Oxygen Sensing Probe 
The probe used to read the oxygen concentration is placed into the oxygen sensing module, and 
relays information to the NeoFox Viewing SystemTM for analysis. 
 
To read the oxygen concentration, a fiber optic probe seen in Figure 16 is placed against 
the glass directly in front of the oxygen sensing patch. This probe emits a blue light (450 nm). In 
the presence of blue light and oxygen, the patch emits florescence at visible wavelengths. This 
florescence is collected by and sent back through the same probe for detection by an avalanche 
photodiode. This reading for florescence intensity is measured relative to the initial emission of 
the blue light. It is then correlated to an oxygen concentration using the Stern-Volmer equation. 
Each oxygen sensor is calibrated prior to each use. It is important to calibrate the sensors, as their 
properties gradually change over time. 
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A2. Residence Time Distribution Analysis 
A2.1 System Design and Preparation 
To collect data for the residence time distribution analysis, the bioreactor system had to 
be set up to allow for dye data collection. Initially, the scaffold disks were purged of air using the 
technique outlined in Section 2.2. DI water was pumped through the cassette, purging the system 
of any air. The scaffold disks were placed into the cassette, and DI water was again pumped 
through the cassette and scaffold, purging the system of any residual air. Entrance and Exit are 
labeled in Figure 18. Once all air was removed, the Exit was clamped, and the DI line to the 
entrance was disconnected from the Entrance. The line from the dye reservoir was connected to 
the Entrance, and the clamp was removed from the Exit. Dye solution was pumped through the 
scaffold, in line with arrows shown in Figure 18, at the desired flow rate. Effluent was collected 
at the Exit, and was analyzed for dye composition. 
 
Figure 18: Cassette Cross-sectional View 
Cross-sectional view of the cassette holding 4 scaffold disk layers. Arrows indicate the direction 
of flow through the cassette. Entrance and exit to the cassette are labeled, and are referred to as 
such. 
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A2.2 Residence Time Analysis Functions 
 The cumulative distribution function, F(t), is indicative of the amount of time a particular 
molecule of fluid has spent in the bioreactor. This function is plotted against time, showing the 
fraction of molecules that has spent that amount of time (t) or less in the bioreactor [97]. For 
example, if F(1000) = 0.85, it would mean that 85% of the molecules exiting at t=1000 seconds 
have spent no more than 1000 seconds in the bioreactor system. Figure 19 shows example plots 
of the cumulative distribution function relative to time in seconds for each flow rate tested. From 
these graphs, it can be deduced that as flow rate increases, the less time it takes to reach a F(t) 
value of 1. 
 The residence time distribution function, E(t), is also used to describe how long particular 
molecules spent in the reactor, where the derivative of E(t) can be used to determine the mean 
residence time [97]. This function shows what portion of molecules likely spent the associated 
time, t, in the reactor system. Figure 20 shows an example of the plot of E(t) with respect to time 
in seconds for each flow rate tested. 
 The normalized residence time distribution function, E(q), gives an indication of the 
residence time distribution function so that it can be compared to reactors of different sizes. 
Figure 21 shows an example plot of E(q), allowing the derived functions to be compared with 
literature values for each flow rate tested. Figure 22 shows a theoretical normalized residence 
time distribution function plot for laminar flow reactor, which shows similar characteristics to 
experimentally obtained plots for all flow rates tested. Previous research likened the flow 
characteristics of these bioreactor systems to plug flow. However, experimentally obtained E(q) 
plots do are not comparable to theoretical plug flow graphs, indicating the current bioreactor 
design is not well approximated by plug flow. Figure 23 shows what normalized residence time 
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distribution functions for plug flow would look like with varying amounts of dispersion, none of 
which have the same characteristic spike and subsequent drop seen in experimental normalized 
residence time distribution functions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Cumulative Distribution Functions 
Example graphs of the cumulative distribution functions, F(t), for each flow rate tested are 
plotted against time (t) in seconds. These graphs show the approximate time at which all 
molecules in the reactor at time zero have exited the system. Each graph corresponds to a 
particular flow rate: (A) 150 µL/min, (B) 300 µL/min, (C) 450 µL/min, (D) 600 µL/min, and (E) 
750 µL/min. 
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Figure 20: Residence Time Distribution Functions 
Example graphs of the residence time distribution functions, E(t), for each flow rate tested are 
plotted against time (t) in seconds. These graphs show the approximate time at which an amount 
of molecules in the reactor at time zero have exited the system. Each graph corresponds to a 
particular flow rate: (A) 150 µL/min, (B) 300 µL/min, (C) 450 µL/min, (D) 600 µL/min, and (E) 
750 µL/min. 
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Figure 21: Normalized Residence Time Distribution Functions 
Example graphs of the normalized residence time distribution functions, E(q), for each flow rate 
tested are plotted against theta (q). These graphs show the approximate time at which an amount 
of molecules the reactor at time zero have exited the system, normalized to residence time to 
allow for comparison to other reactor sizes. Each graph corresponds to a particular flow rate: 
(A) 150 µL/min, (B) 300 µL/min, (C) 450 µL/min, (D) 600 µL/min, and (E) 750 µL/min. 
 
 
A B 
C D 
E 
	 68	
 
Figure 22: Laminar Flow Theoretical Normalized Residence Time Distribution Function 
Theoretical normalized residence time distribution functions, E(q), for a laminar flow reactor, 
adapted from Figure 13-9 in Fogler [97]. This graph serves as a comparison to experimentally 
obtained normalized residence time distribution functions. 
 
 
 
Figure 23: Plug Flow Theoretical Normalized Residence Time Distribution Function 
Theoretical normalized residence time distribution functions, E(q), for a plug flow reactor, 
adapted from Levenspiel [101]. This graph serves as a comparison to experimentally obtained 
normalized residence time distribution functions. 
